A case report of sporadic Creutzfeldt-Jakob disease presenting with progressive opsoclonus-myoclonus-ataxia-Plus (OMAS-Plus) phenotype.

PrionSep 21, 2026 (epub)

Richard Hulej, Pavol Skáčik, Dana Žáková et al.

✦ AI-curated · Sources linked

Case in brief

A 63-year-old man presented with progressive dysarthria and bulbar symptoms, initially suggestive of myasthenia gravis. His condition deteriorated, leading to right-predominant hemiataxia, polymyoclonus, and cognitive decline. Despite extensive testing and treatment with corticosteroids, no improvement was noted. Ultimately, brain MRI and CSF analysis confirmed sporadic Creutzfeldt-Jakob disease (sCJD) of the MM1 subtype.

What made this case unusual

The case highlights an atypical presentation of sCJD characterized by an opsoclonus-myoclonus-ataxia-plus (OMAS-plus) phenotype, which can mislead diagnosis towards treatable conditions.

Diagnostic / clinical pearl

Clinicians should consider prion disease in cases of rapidly progressive neurological symptoms, even when initial presentations suggest treatable disorders.

Why it matters

Recognizing atypical presentations of sCJD can prevent misdiagnosis and ensure timely consideration of prion disease in similar cases.

Source

Published in Prion. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.